The setback affects one of the most established technologies in vaccines – used against the human papillomavirus, hepatitis B and pertussis among other pathogens – which aims to introduce lab-made proteins into the body to prod the immune system into developing a targeted defence against the novel coronavirus.

EU leaders clinch deal on tougher 2030 climate goal

Dec 11, 2020

Leaders of the 27 member states agreed to cut their net greenhouse gas emissions by at least 55% from 1990 levels by 2030, substantially toughening an existing 40% target.

The EU wants to reach “net zero” emissions by 2050, a deadline that scientists say the world must meet to avert the most catastrophic impacts of climate change.

European Council President Charles Michel, who chaired the talks, called the EU the leader in the fight against climate change, and said the target had been hard-fought, but was “credible”.European Commission President Ursula von der Leyen said it would put the bloc “on a clear path towards climate neutrality in 2050”.

ADB launches $9 billion Covid-19 vaccine initiative for its developing member economies

Dec 11, 2020

“As ADB’s developing members prepare to vaccinate their people as soon as possible, they need financing to procure vaccines as well as appropriate plans and knowledge to be able to safely, equitably, and efficiently manage the vaccination process,” ADB President Masatsugu Asakawa said.

U.S. FDA authorizes Pfizer COVID-19 vaccine for emergency use

Dec 11, 2020

Healthcare workers and elderly people in long-term care facilities are expected to be the main recipients of a first round of 2.9 million doses.

Cases are surging in the United States, with thousands of death per day, while hospital intensive care units across the country are nearing capacity, threatening to overwhelm healthcare systems.

« Older Entries

Next Entries »

Briefs